Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Agere Expands Manufacturing Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Agere Expands Manufacturing Capabilities

Adds cGMP spray drying services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Agere Pharmaceuticals has added cGMP manufacturing capabilities to support clients entering Phase IIb trials. The new capacity extends services for formulation development to oral bioavailability of BCS II and IV compounds.  
 
“We’ve extended our cGMP spray drying capabilities in response to our clients’ requests to continue with Agere as they enter Phase IIb clinical trials,” said Marshall Crew, Agere’s president and chief executive officer. “This is a natural progression for us, as expanding services delivers efficiencies to our clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics